• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

强化血糖控制对 2 型糖尿病患者心血管事件发生率的影响:一项荟萃分析。

Effects of intensive glucose control on incidence of cardiovascular events in patients with type 2 diabetes: a meta-analysis.

机构信息

Shanghai Institute of Cardiovascular Disease, Zhongshan Hospital, Fudan University, 180 Fenglin Road, Shanghai 200032, China.

出版信息

Ann Med. 2010 May 6;42(4):305-15. doi: 10.3109/07853891003796752.

DOI:10.3109/07853891003796752
PMID:20429797
Abstract

BACKGROUND

The effects of intensive glucose control over conventional glucose control on cardiovascular outcomes of patients with type 2 diabetes remain uncertain.

METHODS

We searched MEDLINE, EMBASE, and the Cochrane database to identify randomized controlled trials that compared the effects of intensive glucose control and conventional glucose control, on cardiovascular events in patients with type 2 diabetes.

RESULTS

Seven trials involving 34,144 participants with type 2 diabetes were included. Intensive glucose control significantly reduced major cardiovascular events by 10% (relative risk (RR) 0.90, 95% CI 0.85-0.96; P = 0.0006), and non-fatal myocardial infarction by 16% (0.84, 95% CI 0.76-0.93; P = 0.0006) at the expense of increased incidence of severe hypoglycemia (2.30, 95% CI 1.74-3.03; P < 0.00001), while all-cause mortality, cardiovascular death, non-fatal stroke, and heart failure were similar between the two groups. Subgroup analyses showed that patients with longer follow-up duration, shorter diabetic duration, less glycosylated hemoglobin (HbA1c) reduction, higher HbA1c concentration at follow-up, and lower base-line HbA1c benefited more from intensive glucose control.

CONCLUSION

An intensive glucose control strategy can effectively reduce the risk of major cardiovascular events but at the expense of a significantly increased risk of severe hypoglycemia in patients with type 2 diabetes.

摘要

背景

强化血糖控制对比常规血糖控制对 2 型糖尿病患者心血管结局的影响仍不确定。

方法

我们检索了 MEDLINE、EMBASE 和 Cochrane 数据库,以确定比较强化血糖控制与常规血糖控制对 2 型糖尿病患者心血管事件影响的随机对照试验。

结果

纳入了 7 项涉及 34144 例 2 型糖尿病患者的试验。强化血糖控制显著降低了 10%的主要心血管事件(相对风险(RR)0.90,95%置信区间(CI)0.85-0.96;P=0.0006)和 16%的非致死性心肌梗死(0.84,95%CI 0.76-0.93;P=0.0006),但其代价是严重低血糖发生率增加(2.30,95%CI 1.74-3.03;P<0.00001),而两组间全因死亡率、心血管死亡率、非致死性卒中和心力衰竭无差异。亚组分析显示,随访时间更长、糖尿病病程更短、糖化血红蛋白(HbA1c)降幅更小、随访时 HbA1c 浓度更高、基线 HbA1c 更低的患者从强化血糖控制中获益更多。

结论

强化血糖控制策略可有效降低 2 型糖尿病患者主要心血管事件的风险,但会显著增加严重低血糖的风险。

相似文献

1
Effects of intensive glucose control on incidence of cardiovascular events in patients with type 2 diabetes: a meta-analysis.强化血糖控制对 2 型糖尿病患者心血管事件发生率的影响:一项荟萃分析。
Ann Med. 2010 May 6;42(4):305-15. doi: 10.3109/07853891003796752.
2
Prevention of cardiovascular disease through glycemic control in type 2 diabetes: a meta-analysis of randomized clinical trials.通过控制 2 型糖尿病患者的血糖水平来预防心血管疾病:一项随机临床试验的荟萃分析。
Nutr Metab Cardiovasc Dis. 2009 Nov;19(9):604-12. doi: 10.1016/j.numecd.2009.03.021. Epub 2009 May 8.
3
Early and intensive therapy for management of hyperglycemia and cardiovascular risk factors in patients with type 2 diabetes.2 型糖尿病患者的高血糖和心血管危险因素的早期强化治疗。
Clin Ther. 2011 Jun;33(6):665-78. doi: 10.1016/j.clinthera.2011.04.025.
4
Intensive glycemic control has no impact on the risk of heart failure in type 2 diabetic patients: evidence from a 37,229 patient meta-analysis.强化血糖控制对 2 型糖尿病患者心力衰竭风险没有影响:来自 37229 名患者的荟萃分析证据。
Am Heart J. 2011 Nov;162(5):938-948.e2. doi: 10.1016/j.ahj.2011.07.030. Epub 2011 Oct 7.
5
Does intensive glycemic control improve cardiovascular outcomes?强化血糖控制能否改善心血管结局?
Nat Clin Pract Endocrinol Metab. 2008 Oct;4(10):529. doi: 10.1038/ncpendmet0953.
6
Fibrates in the prevention of cardiovascular disease in patients with type 2 diabetes mellitus: meta-analysis of randomised controlled trials.贝特类药物预防2型糖尿病患者心血管疾病:随机对照试验的荟萃分析
Curr Med Res Opin. 2006 Mar;22(3):617-23. doi: 10.1185/030079906X89865.
7
Aspirin for primary prevention of cardiovascular events in patients with diabetes: A meta-analysis.阿司匹林用于糖尿病患者心血管事件一级预防的荟萃分析。
Diabetes Res Clin Pract. 2010 Feb;87(2):211-8. doi: 10.1016/j.diabres.2009.09.029. Epub 2009 Oct 23.
8
Pharmacologic prevention of microvascular and macrovascular complications in diabetes mellitus: implications of the results of recent clinical trials in type 2 diabetes.药物预防 2 型糖尿病的微血管和大血管并发症:近期临床试验结果的意义。
Am J Cardiovasc Drugs. 2012 Feb 1;12(1):7-22. doi: 10.2165/11594650-000000000-00000.
9
The association between intensive glycemic control and vascular complications in type 2 diabetes mellitus: a meta-analysis.强化血糖控制与 2 型糖尿病血管并发症的关系:一项荟萃分析。
Nutr Metab Cardiovasc Dis. 2009 Nov;19(9):596-603. doi: 10.1016/j.numecd.2009.07.004. Epub 2009 Oct 9.
10
Effect of intensive glycemic control on cardiovascular outcomes and all-cause mortality in type 2 diabetes: Overview and metaanalysis of five trials.强化血糖控制对 2 型糖尿病患者心血管结局和全因死亡率的影响:五项试验的概述和荟萃分析。
Diabetes Res Clin Pract. 2009 Dec;86 Suppl 1:S57-62. doi: 10.1016/S0168-8227(09)70011-7.

引用本文的文献

1
European Stroke Organisation (ESO) guideline on pharmacological interventions for long-term secondary prevention after ischaemic stroke or transient ischaemic attack.欧洲卒中组织(ESO)关于缺血性卒中或短暂性脑缺血发作后长期二级预防的药物干预指南。
Eur Stroke J. 2022 Sep;7(3):I-II. doi: 10.1177/23969873221100032. Epub 2022 Jun 3.
2
Time to cardiovascular benefits of empagliflozin: a post hoc observation from the EMPA-REG OUTCOME trial.恩格列净对心血管获益的时间:来自 EMPA-REG OUTCOME 试验的事后观察。
ESC Heart Fail. 2021 Aug;8(4):2603-2607. doi: 10.1002/ehf2.13374. Epub 2021 Jun 16.
3
Cost-effectiveness and budget impact of liraglutide in type 2 diabetes patients with elevated cardiovascular risk: a US-managed care perspective.
利拉鲁肽对心血管风险升高的2型糖尿病患者的成本效益和预算影响:美国管理式医疗视角
Clinicoecon Outcomes Res. 2018 Nov 14;10:791-803. doi: 10.2147/CEOR.S180067. eCollection 2018.
4
Oral Insulin Delivery in a Physiologic Context: Review.生理环境下的口服胰岛素递送:综述
J Diabetes Sci Technol. 2017 Jul;11(4):825-832. doi: 10.1177/1932296817691303. Epub 2017 Feb 2.
5
The HbA1c and all-cause mortality relationship in patients with type 2 diabetes is J-shaped: a meta-analysis of observational studies.2型糖尿病患者糖化血红蛋白(HbA1c)与全因死亡率的关系呈J形:观察性研究的荟萃分析
Rev Diabet Stud. 2014 Summer;11(2):138-52. doi: 10.1900/RDS.2014.11.138. Epub 2014 Aug 10.
6
Comorbid Heart Failure and Renal Impairment: Epidemiology and Management.合并心力衰竭与肾功能损害:流行病学与管理
Cardiorenal Med. 2012 Dec;2(4):281-297. doi: 10.1159/000342487. Epub 2012 Oct 31.
7
Intensive glycaemic control for patients with type 2 diabetes: systematic review with meta-analysis and trial sequential analysis of randomised clinical trials.强化血糖控制对 2 型糖尿病患者的影响:随机临床试验的系统评价和试验序贯分析。
BMJ. 2011 Nov 24;343:d6898. doi: 10.1136/bmj.d6898.